Aptevo Therapeutics (APVO) News Today → Write this ticker symbol down… (From StocksToTrade) (Ad) Free APVO Stock Alerts $0.73 +0.02 (+2.82%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | investorplace.comAPVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024May 2, 2024 | msn.comWhy Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving PremarketApril 11, 2024 | msn.comWhy Aptevo Therapeutics Stock Is CrateringApril 11, 2024 | investorplace.comWhy Is Aptevo Therapeutics (APVO) Stock Down 56% Today?March 7, 2024 | marketwatch.comAptevo Therapeutics Up 20% on Positive Interim Data for Tumor DrugMarch 7, 2024 | finance.yahoo.comAlligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 11:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 10:03 AM with a stated reason of "LULD pause." Trading set to resume at 11:03 AM. March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 11:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 10:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 09:03 AM with a stated reason of "LULD pause."March 6, 2024 | ca.finance.yahoo.comAptevo Therapeutics Inc (AP8N.BE)March 6, 2024 | investing.comAptevo Therapeutics enacts reverse stock split to meet Nasdaq requirementsMarch 6, 2024 | marketbeat.comTrading was temporarily halted for "APVO" at 07:03 PM with a stated reason of "News pending."March 5, 2024 | investorplace.comAPVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q4 2023March 5, 2024 | finance.yahoo.comAptevo Therapeutics Inc (AP8N.DU)March 4, 2024 | msn.comAptevo Therapeutics down 13%, will effect 1-for-44 reverse stock splitMarch 1, 2024 | uk.finance.yahoo.comPD-1 and PD-L1 Inhibitors Competitive Landscape Report 2024: Clinical Assessment of Over 200 Drugs Being Developed by More than 180 CompaniesFebruary 9, 2024 | investing.comAptevo Therapeutics Inc (APVO)February 7, 2024 | msn.comAptevo Therapeutics Stockholders Approve Reverse SplitJanuary 24, 2024 | finance.yahoo.comAptevo Therapeutics Inc. (APVO)November 22, 2023 | msn.comAptevo Therapeutics files to sell up to 32.03M shares of common stock for holdersNovember 14, 2023 | msn.comAptevo Therapeutics GAAP EPS of -$0.50November 14, 2023 | finance.yahoo.comAptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business UpdateNovember 1, 2023 | finanznachrichten.deAptevo Therapeutics: Aptevo to Present at Bio-Europe ConferenceNovember 1, 2023 | finance.yahoo.comAptevo to Present at Bio-Europe ConferenceOctober 21, 2023 | thestreet.comWith New Cash Aptevo Goes It Alone on Prostate Drug, Shares Up - Biotech MoversSeptember 26, 2023 | money.usnews.comAptevo Therapeutics IncAugust 10, 2023 | finance.yahoo.comAptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business UpdateAugust 4, 2023 | finance.yahoo.comAptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public OfferingAugust 3, 2023 | msn.comAptevo Therapeutics (APVO) Price Target Increased by 24.14% to 18.36August 2, 2023 | benzinga.comWhy Aptevo Therapeutics Stock Is Getting ObliteratedAugust 2, 2023 | investorplace.comWhy Is Aptevo Therapeutics (APVO) Stock Down 33% Today?August 2, 2023 | msn.comAptevo Therapeutics down 25% after pricing $5M offeringAugust 2, 2023 | finance.yahoo.comAptevo Therapeutics Inc. Announces Pricing of $5 Million Public OfferingJuly 18, 2023 | finanznachrichten.deAptevo Therapeutics: Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AMLJuly 18, 2023 | benzinga.comAptevo Therapeutics Stock Is Sinking Today - Here's WhyJune 29, 2023 | ca.finance.yahoo.comAPVO - Aptevo Therapeutics Inc.May 11, 2023 | finance.yahoo.comAptevo Therapeutics Reports 1Q23 Financial Results and Provides Business UpdateApril 1, 2023 | finance.yahoo.comAptevo Therapeutics Full Year 2022 Earnings: EPS Beats ExpectationsMarch 30, 2023 | finance.yahoo.comAptevo Therapeutics Raises $9.6 Million in Non-Dilutive FundingMarch 30, 2023 | finance.yahoo.comAptevo Therapeutics Reports 2022 Financial Results and Provides Business UpdateJanuary 9, 2023 | finance.yahoo.comAptevo Therapeutics Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid TumorsDecember 20, 2022 | finance.yahoo.comAptevo Stock Jumps As Acute Myeloid Leukemia Combo Therapy Achieves 100% Clinical Benefit RateDecember 14, 2022 | benzinga.comShort Volatility Alert: Aptevo TherapeuticDecember 12, 2022 | finance.yahoo.com100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)November 10, 2022 | finance.yahoo.comAptevo Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 9, 2022 | finance.yahoo.comAlligator Bioscience & Aptevo Therapeutics Announce Publication Highlighting ALG.APV-527 Preclinical Data in Peer-Reviewed Journal Molecular Cancer TherapeuticsNovember 3, 2022 | finance.yahoo.comAptevo Therapeutics Announces Poster Presentation at the 64th American Society of Hematology Annual Meeting and ExpositionOctober 1, 2022 | seekingalpha.comAPVO Aptevo Therapeutics Inc. Get Aptevo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… APVO Media Mentions By Week APVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APVO News Sentiment▼1.110.79▲Average Medical News Sentiment APVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APVO Articles This Week▼30▲APVO Articles Average Week Get Aptevo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MBIO News ADXS News SNOA News CYCC News ZVSA News BDRX News LGVN News QNRX News ONCO News ARAV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APVO) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
